CDx

Careers

FR

Comparable detection of large tumor-derived vesicles (oncosomes) by known CTC platforms: potential new analyte for biomarker monitoring?

Affiches Apr 27, 2025

Oncologie

|

IHC/IF, Protéomique, Séquençage

April 27, 2025

Eszter Papp, Pieter Mestdagh

Comparable detection of large tumor-derived vesicles (oncosomes) by known CTC platforms: potential new analyte for biomarker monitoring?

Biomarker strategies to support success at every stage of therapy development

Poster: analytical validation of high-resolution ctDNA profiling with TSO500 v2.0.

Scaling Liquid Biopsy Biomarker Discovery: multi-center, Analytical Validation of high resolution ctDNA Profiling Using TSO500 ctDNA v2.0 on NovaSeq X Plus

Validation of an ultra-sensitive assay for biomarker testing in NSCLC patients as Clinical Trial Assay (CTA)

CellCarta has the multi-modal capabilities, scientific depth, and harmonized global footprint needed to advance even the most complex programs in precision medicine.